Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
1.420
+0.015 (1.07%)
At close: Nov 26, 2025, 4:00 PM EST
1.600
+0.180 (12.68%)
After-hours: Nov 26, 2025, 7:48 PM EST
Bone Biologics Market Cap
Bone Biologics has a market cap or net worth of $2.55 million as of November 26, 2025. Its market cap has decreased by -7.89% in one year.
Market Cap
2.55M
Enterprise Value
-3.50M
1-Year Change
-7.89%
Ranking
Category
Stock Price
$1.42
Market Cap Chart
Since March 31, 2016, Bone Biologics's market cap has decreased from $155.72M to $2.55M, a decrease of -98.36%. That is a compound annual growth rate of -34.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 2.55M | 10.05% |
| Dec 31, 2024 | 2.32M | -4.06% |
| Dec 29, 2023 | 2.41M | -24.75% |
| Dec 30, 2022 | 3.21M | -91.19% |
| Dec 31, 2021 | 36.43M | -58.55% |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |